Purchase of BioRad QX200 Droplet generator/reader

The contract involves the purchase of a BioRad QX200 Droplet generator and reader system to support the development of screening methods for Hepatitis A. This digital PCR system will enhance the ability to conduct precise molecular analyses, crucial for accurate and efficient pathogen detection. The Food and Drug Administration (FDA) is the agency responsible for this acquisition, which falls under the NAICS code for professional, scientific, and technical services. Details about the solicitation number, specific location for performance, and set-aside types are not specified. The forecast for this acquisition was posted in March 2026, and the primary point of contact for program-related inquiries is the Hfp Acquisition Liaison at the FDA, while the contracting officer is yet to be designated. This purchase aims to strengthen the FDA’s capabilities in disease screening and public health safety.